Cite
MLA Citation
yiyun shi et al.. “576. Half-dose Valganciclovir Prophylaxis is Safe and Cost-effective in CMV Seropositive Renal Transplant Recipients.” Open forum infectious diseases, vol. 7, n.d., pp. S352–S353. http://access.bl.uk/ark:/81055/vdc_100121927421.0x000005